Overcoming Temozolomide Resistance in Glioblastoma via Enhanced NAD(+) Bioavailability and Inhibition of Poly-ADP-Ribose Glycohydrolase.
Li J, Koczor CA, Saville KM, Hayat F, Beiser A, McClellan S, Migaud ME, Sobol RW
Cancers (Basel). 2022 Jul 22;14(15). pii: cancers14153572. doi: 10.3390/cancers14153572.
(Link opens in a new window)
PubMed
(Link opens in a new window)
Article
Plasmids from Article
ID | Plasmid | Purpose |
---|---|---|
187654 | pIRES-Puro-MGMT | Expresses hMGMT together with the puromycin resistance gene via an IRES. |